LFM-A13
Suppliers
Names
[ CAS No. ]:
244240-24-2
[ Name ]:
LFM-A13
[Synonym ]:
2-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-, (2Z)-
a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide
(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide
trans-4,5-didehydro-neral
dehydrocitral
trans-dehydroneral
2,4,6-Octatrienal,3,7-dimethyl
(2Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
Chemical & Physical Properties
[ Density]:
1.9±0.1 g/cm3
[ Boiling Point ]:
487.9±45.0 °C at 760 mmHg
[ Molecular Formula ]:
C11H8Br2N2O2
[ Molecular Weight ]:
360.001
[ Flash Point ]:
248.9±28.7 °C
[ Exact Mass ]:
357.895233
[ PSA ]:
73.12000
[ LogP ]:
3.42
[ Appearance of Characters ]:
powder | white
[ Vapour Pressure ]:
0.0±1.3 mmHg at 25°C
[ Index of Refraction ]:
1.677
[ Storage condition ]:
−20°C
[ Water Solubility ]:
DMSO: 15 mg/mL
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302-H312-H332
[ Precautionary Statements ]:
P280
[ Hazard Codes ]:
Xn: Harmful;
[ Risk Phrases ]:
20/21/22
[ Safety Phrases ]:
36/37
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
EMBO Mol. Med. 7(3) , 240-58, (2015)
Transplant recipients on calcineurin inhibitors are at high risk of invasive fungal infection. Understanding how calcineurin inhibitors impair fungal immunity is a key priority for defining risk of in...
Mol. Cancer 9 , 267, (2010)
Recently, much attention has been focused on gaining a better understanding of the different populations of cells within a tumor and their contribution to cancer progression. One of the most commonly ...
J. Exp. Med. 206(4) , 937-52, (2009)
Differentiation and recruitment of alternatively activated macrophages (AAMacs) are hallmarks of several inflammatory conditions associated with infection, allergy, diabetes, and cancer. AAMacs are de...